Fennec Pharmaceuticals annual gross margin
2022
2023
2024
2025
Fennec Pharmaceuticals Gross Margin Growth & History (FENC)
Fennec Pharmaceuticals's gross margin was 91.57% for fiscal 2025.
View full Fennec Pharmaceuticals company overviewFennec Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 91.57% | −1.73 pp |
| 2024 | 2024-12-31 | 93.30% | +9.23 pp |
| 2023 | 2023-12-31 | 84.07% | +2.16 pp |
| 2022 | 2022-12-31 | 81.91% | — |
Fennec Pharmaceuticals quarterly gross margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 95.97% | +5.98 pp |
| Q1 2026 | 2026-03-31 | 96.23% | +0.49 pp |
| Q4 2025 | 2025-12-31 | 87.20% | — |
| Q3 2025 | 2025-09-30 | 94.70% | — |
| Q2 2025 | 2025-06-30 | 89.98% | — |
| Q1 2025 | 2025-03-31 | 95.74% | — |
| Q4 2023 | 2023-12-31 | 73.79% | — |
| Q3 2023 | 2023-09-30 | 94.92% | — |
| Q2 2023 | 2023-06-30 | 95.55% | — |
| Q1 2023 | 2023-03-31 | 94.34% | — |
Fennec Pharmaceuticals gross margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Fennec Pharmaceuticals's gross margin increased from 81.91% to 91.57%, a change of +9.66 percentage points. The latest reported quarter, Q2 2026, shows 95.97%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fennec Pharmaceuticals source filings ↗